Review of Intracranial Meningiomas: An Update on Management from Diagnosis to Treatment
Abstract
Intracranial meningiomas represent the most common type of brain tumors. Meningiomas differ widely based on their presenting symptoms, their grade and biological behavior, location, and proximity to critical structures. We review briefly the epidemiology and clinical presentation of meningiomas, and present an overview of diagnostic approaches, as well as the evidence behind the different management strategies in meningioma, with emphasis on shifting paradigms in the surgical approach, and on the different radiation therapy modalities. We also shed light on the diagnostic challenges, and literature gaps in the treatment of meningiomas. Future studies will provide clinicians with more guidance regarding the optimal timing of intervention and the need for adjuvant treatment in completely resected atypical meningiomas.
Keywords
Full Text:
Subscribers OnlyReferences
Marosi C, Hassler M, Roessler K, et al. Meningioma. Crit Rev Oncol Hematol. 2008;67(2):153-171. doi:10.1016/j.critrevonc.2008.01.010.
Ostrom QT, Gittleman H, Liao P, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014. Neuro Oncol. 2017. doi:10.1093/neuonc/nox158.
Longstreth WTJ, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD. Epidemiology of intracranial meningioma. Cancer. 1993;72(3):639-648.
Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology. 2000;54(1):71 LP-71. http://n.neurology.org/content/54/1/71.abstract.
Smith MJ, Higgs JE, Bowers NL, et al. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet. 2011. doi:10.1136/jmg.2010.085241.
Sadetzki S, Flint-Richter P, Ben-Tal T, Nass D. Radiation-induced meningioma: a descriptive study of 253 cases. J Neurosurg. 2002. doi:10.3171/jns.2002.97.5.1078.
Phillips LE, Frankenfeld CL, Drangsholt M, Koepsell TD, van Belle G, Longstreth WTJ. Intracranial meningioma and ionizing radiation in medical and occupational settings. Neurology. 2005;64(2):350-352. doi:10.1212/01.WNL.0000149766.65843.19.
Custer BS, Koepsell TD, Mueller BA. The association between breast carcinoma and meningioma in women. Cancer. 2002. doi:10.1002/cncr.10410.
Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307-314. doi:10.1007/s11060-010-0386-3.
Benson VS, Pirie K, Schüz J, Reeves GK, Beral V, Green J. Mobile phone use and risk of brain neoplasms and other cancers: Prospective study. J Immunol. 2015;195(5):792-802. doi:10.1093/ije/dyt072.
Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131(6):803-820. doi:10.1007/s00401-016-1545-1.
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO Classification of tumours of the central nervous system. 2007:97-109. doi:10.1007/s00401-007-0243-4.
Yue NC, Longstreth WT, Elster AD, Jungreis CA, O’Leary DH, Poirier VC. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology. 1997;202(1):41-46. doi:10.1148/radiology.202.1.8988190.
Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821-1828. doi:10.1056/NEJMoa070972.
Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg. 2000;92(5):766-770. doi:10.3171/jns.2000.92.5.0766.
Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet (London, England). 2004;363(9420):1535-1543. doi:10.1016/S0140-6736(04)16153-9.
Lieu AS, Howng SL. Intracranial meningiomas and epilepsy: incidence, prognosis and influencing factors. Epilepsy Res. 2000;38(1):45-52.
Ramamurthi B, Ravi B, Ramachandran V. Convulsions with meningiomas: incidence and significance. Surg Neurol. 1980;14(6):415-416.
Kawaguchi T, Kameyama S, Tanaka R. Peritumoral edema and seizure in patients with cerebral convexity and parasagittal meningiomas. Neurol Med Chir (Tokyo). 1996;36(8):564-568.
Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg. 2016;124(6):1552-1561. doi:10.3171/2015.4.JNS142742.
Whittle IR, Pringle AM, Taylor R. Effects of resective surgery for left-sided intracranial tumours on language function: A prospective study. Lancet. 1998;351(9108):1014-1018. doi:10.1016/S0140-6736(97)08295-0.
Rohringer M, Sutherland GR, Louw DF, Sima AAF. Incidence and clinicopathological features of meningioma. J Neurosurg. 1989;71(5):665-672. doi:10.3171/jns.1989.71.5.0665.
Buetow MP, Buetow PC, Smirniotopoulos JG. Typical, atypical, and misleading features in meningioma. Radiographics. 1991;11:1087-1106. doi:10.1148/radiographics.11.6.1749851.
Tamrazi B, Shiroishi MS, Liu C-SJ. Advanced Imaging of Intracranial Meningiomas. Neurosurg Clin N Am. 2016;27(2):137-143. doi:10.1016/j.nec.2015.11.004.
Chamoun R, Krisht KM, Couldwell WT. Incidental meningiomas. Neurosurg Focus. 2011;31(6):E19. doi:10.3171/2011.9.FOCUS11220.
Grau S, Schueller U, Weiss C, Tonn JC. Primary meningeal T-cell lymphoma at the clivus mimicking a meningioma. World Neurosurg. 2010;74(4-5):513-516. doi:10.1016/j.wneu.2010.06.020.
Paiva J, King J, Chandra R. Extra-axial Hodgkin’s lymphoma with bony hyperostosis mimicking meningioma. J Clin Neurosci. 2011;18(5):725-727. doi:10.1016/j.jocn.2010.09.015.
Kasliwal MK, Suri A, Gupta DK, Suri V, Rishi A, Sharma BS. Sphenoid wing inflammatory pseudotumor mimicking a clinoidal meningioma: case report and review of the literature. Surg Neurol. 2008;70(5):509-513. doi:10.1016/j.surneu.2007.07.075.
Salunke P, Kovai P, Sura S, Gupta K. Extra-axial ependymoma mimicking a parasagittal meningioma. J Clin Neurosci. 2011;18(3):418-420. doi:10.1016/j.jocn.2010.04.042.
Wilms G, Lammens M, Marchal G, et al. Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr. 1989;13(5):763-768.
Goldsher D, Litt AW, Pinto RS, Bannon KR, Kricheff II. Dural “tail” associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology. 1990;176(2):447-450. doi:10.1148/radiology.176.2.2367659.
Bourekas EC, Wildenhain P, Lewin JS, et al. The dural tail sign revisited. AJNR Am J Neuroradiol. 1995;16(7):1514-1516.
Sotoudeh H, Yazdi HR. A review on dural tail sign. World J Radiol. 2010;2(5):188-192. doi:10.4329/wjr.v2.i5.188.
Rokni-Yazdi H, Sotoudeh H. Prevalence of “dural tail sign” in patients with different intracranial pathologies. Eur J Radiol. 2006;60(1):42-45. doi:10.1016/j.ejrad.2006.04.003.
Mujagić S, Bećirević-Ibrišević J, Vržuljević-Martić V, Ercegović Z, Korkut D, Moranjkić M. Dural tail sign adjacent to different intracranial lesions on contrast-enhanced MR images. J Heal Sci J Heal Sci www.jhsci.ba. 2011;1(2).
Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17(9):e383-e391. doi:10.1016/S1470-2045(16)30321-7.
Kiroglu Y, Calli C, Karabulut N, Oncel C. Intracranial calcifications on CT. Diagn Interv Radiol. 2010;16(4):263-269. doi:10.4261/1305-3825.DIR.2626-09.1.
Oya S, Kim S-H, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg. 2011;114(5):1250-1256. doi:10.3171/2010.12.JNS101623.
Nowosielski M, Galldiks N, Iglseder S, et al. Diagnostic challenges in meningioma. Neuro Oncol. 2017;19(12):1588-1598. doi:10.1093/neuonc/nox101.
Saloner D, Uzelac A, Hetts S, Martin A, Dillon W. Modern meningioma imaging techniques. J Neurooncol. 2010;99(3):333-340. doi:10.1007/s11060-010-0367-6.
Tan LA, Boco T, Johnson AK, et al. Magnetic resonance imaging characteristics of typical and atypical/anaplastic meningiomas - Case series and literature review. Br J Neurosurg. September 2014:1-5. doi:10.3109/02688697.2014.957647.
Yin B, Liu L, Zhang BY, Li YX, Li Y, Geng DY. Correlating apparent diffusion coefficients with histopathologic findings on meningiomas. Eur J Radiol. 2012;81(12):4050-4056. doi:10.1016/j.ejrad.2012.06.002.
Watanabe Y, Yamasaki F, Kajiwara Y, et al. Preoperative histological grading of meningiomas using apparent diffusion coefficient at 3T MRI. Eur J Radiol. 2013;82(4):658-663. doi:10.1016/j.ejrad.2012.11.037.
Surov A, Ginat DT, Sanverdi E, et al. Use of diffusion weighted imaging in differentiating between malignant and benign meningiomas. A multicenter analysis. World Neurosurg. 2016;88:598-602. doi:10.1016/j.wneu.2015.10.049.
Dutour A, Kumar U, Panetta R, et al. Expression of somatostatin receptor subtypes in human brain tumors. Int J cancer. 1998;76(5):620-627.
Rachinger W, Stoecklein VM, Terpolilli NA, et al. Increased 68Ga-DOTATATE uptake in PET imaging discriminates meningioma and tumor-free tissue. J Nucl Med. 2015;56(3):347-353. doi:10.2967/jnumed.114.149120.
Collamati F, Pepe A, Bellini F, et al. Toward radioguided surgery with beta- decays: uptake of a somatostatin analogue, DOTATOC, in meningioma and high-grade glioma. J Nucl Med. 2015;56(1):3-8. doi:10.2967/jnumed.114.145995.
Henze M, Dimitrakopoulou-strauss A, Milker-zabel S, et al. Characterization of 68Ga-DOTA-D-Phe1-Tyr3-Octreotide kinetics in patients with meningiomas. J Nucl Med. 2005;46(5):763-769.
Milker-Zabel S, Zabel-du Bois A, Henze M, et al. Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys. 2006;65(1):222-227. doi:10.1016/j.ijrobp.2005.12.006.
Gehler B, Paulsen F, Öksüz MT, et al. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning. Radiat Oncol. 2009;4(1):1-8. doi:10.1186/1748-717X-4-56.
Nakasu S, Fukami T, Nakajima M, Watanabe K, Ichikawa M, Matsuda M. Growth pattern changes of meningiomas: long-term analysis. Neurosurgery. 2005;56(5):946-955.
Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg. 1995;83(2):222-224. doi:10.3171/jns.1995.83.2.0222.
Firsching RP, Fischer A, Peters R, Thun F, Klug N. Growth rate of incidental meningiomas. J Neurosurg. 1990;73(4):545-547. doi:10.3171/jns.1990.73.4.0545.
Sughrue ME, Rutkowski MJ, Aranda D, Barani IJ, McDermott MW, Parsa AT. Treatment decision making based on the published natural history and growth rate of small meningiomas. J Neurosurg. 2010;113(5):1036-1042. doi:10.3171/2010.3.JNS091966.
Nakamura M, Roser F, Michel J, Jacobs C, Samii M. The natural history of incidental meningiomas. Neurosurgery. 2003;53(1):61-62.
Yoneoka Y, Fujii Y, Tanaka R. Growth of incidental meningiomas. Acta Neurochir (Wien). 2000;142(5):507-511. doi:10.1007/s007010050463.
Mawrin C, Chung C, Preusser M. Biology and clinical management challenges in meningioma. Am Soc Clin Oncol Educ B. 2015;35:e106-15. doi:10.14694/EdBook_AM.2015.35.e106.
Herscovici Z, Rappaport Z, Sulkes J, Danaila L, Rubin G. Natural history of conservatively treated meningiomas. Neurology. 2004;63(6):1133-1134.
Go RS, Taylor B V, Kimmel DW. The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neurology. 1998;51(6):1718-1720.
Yano S, Kuratsu J. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg. 2006;105(4):538-543. doi:10.3171/jns.2006.105.4.538.
Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiat. 1957;20:22.
Gousias K, Schramm J, Simon M. The Simpson grading revisited: aggressive surgery and its place in modern meningioma management. J Neurosurg. 2016. doi:10.3171/2015.9.JNS15754.
Ehresman JS, Garzon-Muvdi T, Rogers D, et al. The relevance of Simpson Grade resections in modern neurosurgical treatment of World Health Organization grade I, II, and III meningiomas. World Neurosurg. 2018. doi:10.1016/j.wneu.2017.10.028.
Oya S, Kawai K, Nakatomi H, Saito N. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg. 2012. doi:10.3171/2012.7.JNS111945a.
Voß KM, Spille DC, Sauerland C, et al. The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value? J Neurooncol. 2017. doi:10.1007/s11060-017-2481-1.
Nanda A, Bir SC, Konar S, Maiti TK, Bollam P. World Health Organization Grade I Convexity Meningiomas: Study on Outcomes, Complications and Recurrence Rates. World Neurosurg. 2016. doi:10.1016/j.wneu.2015.11.050.
Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, et al. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. J Neurosurg. 2016. doi:10.3171/2015.1.JNS142228.
Morokoff AP, Zauberman J, Black PM. Surgery for convexity meningiomas. Neurosurgery. 2008. doi:10.1227/01.NEU.0000310692.80289.28.
Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: Diagnosis, characteristics, and treatment. J Neurooncol. 2010. doi:10.1007/s11060-010-0348-9.
Aghi MK, Carter BS, Cosgrove GR, et al. Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery. 2009. doi:10.1227/01.NEU.0000330399.55586.63.
Compter I, Zaugg K, Houben RMA, et al. High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma A multicentre study. Strahlentherapie und Onkol. 2012. doi:10.1007/s00066-012-0155-7.
Dziuk TW, Woo S, Butler EB, et al. Malignant meningioma: An indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol. 1998. doi:10.1023/A:1005853720926.
Rosenberg LA, Prayson RA, Lee J, et al. Long-Term Experience With World Health Organization Grade III (Malignant) Meningiomas at a Single Institution. Int J Radiat Oncol Biol Phys. 2009. doi:10.1016/j.ijrobp.2008.08.018.
Kano H, Takahashi JA, Katsuki T, et al. Stereotactic radiosurgery for atypical and anaplastic meningiomas. J Neurooncol. 2007. doi:10.1007/s11060-007-9338-y.
Engenhart-Cabillic R, Farhoud A, Sure U, et al. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Strahlentherapie und Onkol. 2006. doi:10.1007/s00066-006-1555-3.
Aizer AA, Arvold ND, Catalano P, et al. Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014. doi:10.1093/neuonc/nou098.
Jenkinson MD, Javadpour M, Haylock BJ, et al. The ROAM/EORTC-1308 trial: Radiation versus observation following surgical resection of atypical Meningioma: study protocol for a randomised controlled trial. Trials. 2015;16(1):519. doi:10.1186/s13063-015-1040-3.
ClinicalTrials.gov. Bethesda [MD]: National Library of Medicine (US). Identifier NCT03180268. Observation or radiation therapy in treating patients with newly diagnosed grade II meningioma that has been completely removed by surgery. https://www.clinicaltrials.gov/ct2/show/NCT03180268?cond=Meningioma&draw=2&rank=13. Published 2017.
Santacroce A, Walier M, Régis J, et al. Long-term tumor control of benign intracranial meningiomas after radiosurgery in a series of 4565 patients. Neurosurgery. 2012. doi:10.1227/NEU.0b013e31822d408a.
Starke RM, Williams BJ, Hiles C, Nguyen JH, Elsharkawy MY, Sheehan JP. Gamma knife surgery for skull base meningiomas. J Neurosurg. 2012;116(3):588-597. doi:10.3171/2011.11.JNS11530.
Unger KR, Lominska CE, Chanyasulkit J, et al. Risk factors for posttreatment edema in patients treated with stereotactic radiosurgery for meningiomas. Neurosurgery. 2012;70(3):639-645. doi:10.1227/NEU.0b013e3182351ae7.
Soldà F, Wharram B, De Ieso PB, Bonner J, Ashley S, Brada M. Long-term efficacy of fractionated radiotherapy for benign meningiomas. Radiother Oncol. 2013. doi:10.1016/j.radonc.2013.10.006.
Litré CF, Colin P, Noudel R, et al. Fractionated Stereotactic Radiotherapy Treatment of Cavernous Sinus Meningiomas: A Study of 100 Cases. Int J Radiat Oncol Biol Phys. 2009. doi:10.1016/j.ijrobp.2008.09.012.
Paulsen F, Doerr S, Wilhelm H, Becker G, Bamberg M, Claßen J. Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2012. doi:10.1016/j.ijrobp.2010.11.018.
Combs SE, Adeberg S, Dittmar JO, et al. Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol. 2013. doi:10.1016/j.radonc.2012.07.008.
Hardesty DA, Wolf AB, Brachman DG, et al. The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg. 2013. doi:10.3171/2012.12.JNS12414.
Cohen-Inbar O, Tata A, Moosa S, Lee C, Sheehan JP. Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation. J Neurosurg. 2017. doi:10.3171/2016.11.JNS161402.
Patibandla MR, Lee C-C, Tata A, Addagada GC, Sheehan JP. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation. J Neurosurg. January 2018:1-11. doi:10.3171/2017.6.JNS17993.
Stafford SL, Pollock BE, Foote RL, et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery. 2001;49(5):1028-1029.
Pollock BE, Stafford SL, Link MJ, Garces YI, Foote RL. Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: Treatment results on the basis of a 22-year experience. Cancer. 2012. doi:10.1002/cncr.26362.
Weber DC, Lomax AJ, Rutz HP, et al. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas. Radiother Oncol. 2004;71(3):251-258. doi:10.1016/j.radonc.2004.02.011.
Weber DC, Schneider R, Goitein G, et al. Spot scanning-based proton therapy for intracranial meningioma: Long-term results from the Paul Scherrer Institute. Int J Radiat Oncol Biol Phys. 2012;83(3):865-871. doi:10.1016/j.ijrobp.2011.08.027.
Boskos C, Feuvret L, Noel G, et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. Int J Radiat Oncol Biol Phys. 2009;75(2):399-406. doi:10.1016/j.ijrobp.2008.10.053.
Halasz LM, Bussire MR, Dennis ER, et al. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys. 2011;81(5):1428-1435. doi:10.1016/j.ijrobp.2010.07.1991.
Noel G, Habrand J-L, Mammar H, et al. Highly conformal therapy using proton component in the management of meningiomas. Preliminary experience of the Centre de Protontherapie d’Orsay. Strahlentherapie und Onkol Organ der Dtsch Rontgengesellschaft . [et al]. 2002;178(9):480-485.
Wenkel E, Thornton AF, Finkelstein D, et al. Benign meningioma: Partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48(5):1363-1370. doi:10.1016/S0360-3016(00)01411-5.
Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: A treatment planning study. Radiother Oncol. 2003;68(1):1-14. doi:10.1016/S0167-8140(03)00117-8.
Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology. 2004;111(5):997-1008. doi:10.1016/j.ophtha.2003.01.002.
Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol. 1992;37(3):167-183. http://www.ncbi.nlm.nih.gov/pubmed/1475751.
Kanamalla US. The optic nerve tram-track sign. Radiology. 2003;227(3):718-719. doi:10.1148/radiol.2273010758.
Jain D, Ebrahimi K, Miller N, Eberhart C. Intraorbital meningiomas. Arch Pathol Lab Med. 2010;134(May):766-770.
Shapey J, Sabin HI, Danesh-Meyer H V., Kaye AH. Diagnosis and management of optic nerve sheath meningiomas. J Clin Neurosci. 2013;20(8):1045-1056. doi:10.1016/j.jocn.2013.03.008.
Kennerdell JS, Maroon JC, Malton M, Warren FA. The management of optic nerve sheath meningiomas. Am J Ophthalmol. 1988;106(4):450-457.
Kim JW, Rizzo JF, Lessell S. Controversies in the management of optic nerve sheath meningiomas. Int Ophthalmol Clin. 2005;45(4):15-23. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=41546821.
Egan RA, Lessell S. A contribution ot the natural history of optic nerve sheath meningiomas. Arch Ophthalmol. 2002;120:1505-1508.
Roser F, Nakamura M, Martini-Thomas R, Samii M, Tatagiba M. The role of surgery in meningiomas involving the optic nerve sheath. Clin Neurol Neurosurg. 2006;108(5):470-476. doi:10.1016/j.clineuro.2005.08.001.
Cristante L. Surgical treatment of meningiomas of the orbit and optic canal: A retrospective study with particular attention to the visual outcome. Acta Neurochir (Wien). 1994;126(1):27-32. doi:10.1007/BF01476490.
Berman D, Miller NR. New concepts in the management of optic nerve sheath meningiomas. Ann Acad Med Singapore. 2006;35(3):168-174.
Eddleman CS, Liu JK. Optic nerve sheath meningioma: current diagnosis and treatment. Neurosurg Focus. 2007;23(5):E4. doi:10.3171/FOC-07/11/E4.
Arvold ND, Lessell S, Bussiere M, et al. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2009;75(4):1166-1172. doi:10.1016/j.ijrobp.2008.12.056.
Bloch O, Sun M, Kaur G, Barani IJ, Parsa AT. Fractionated radiotherapy for optic nerve sheath meningiomas. J Clin Neurosci. 2012;19(9):1210-1215. doi:10.1016/j.jocn.2012.02.010.
Pitz S, Becker G, Schiefer U, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol. 2002;86(11):1265-1268. doi:10.1136/bjo.86.11.1265.
Narayan S, Cornblath WT, Sandler HM, Elner V, Hayman JA. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2003;56(2):537-543.
Turbin RE, Thompson CR, Kennerdell JS, Cockerham KP, Kupersmith MJ. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. 2002;109(5):890-899. doi:10.1016/S0161-6420(02)01017-5.
Goto T, Ohata K. Surgical resectability of skull base meningiomas. Neurol Med Chir (Tokyo). 2016;56(7):372-378. doi:10.2176/nmc.ra.2015-0354.
Moraes FY, Chung C. Radiation for skull base meningiomas: review of the literature on the approach to radiotherapy. Chinese Clin Oncol. 2017;6(S1):S3-S3. doi:10.21037/cco.2017.06.08.
Chen CM, Huang APH, Kuo LT, Tu YK. Contemporary surgical outcome for skull base meningiomas. Neurosurg Rev. 2011;34(3):281-294. doi:10.1007/s10143-011-0321-x.
Starke RM, Przybylowski CJ, Sugoto M, et al. Gamma Knife radiosurgery of large skull base meningiomas. J Neurosurg. 2015;122(2):363-372. doi:10.3171/2014.10.JNS14198.
Sheehan JP, Starke RM, Kano H, et al. Gamma Knife radiosurgery for posterior fossa meningiomas: a multicenter study. 2015;122(June):1479-1489. doi:10.3171/2014.10.JNS14139.Disclosure.
Ichinose T, Goto T, Ishibashi K, Takami T, Ohata K. The role of radical microsurgical resection in multimodal treatment for skull base meningioma. J Neurosurg. 2010;113(5):1072-1078. doi:10.3171/2010.2.JNS091118.
Sahm F, Schrimpf D, Stichel D, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682-694. doi:10.1016/S1470-2045(17)30155-9.
ClinicalTrials.gov. Bethesda [MD]: National Library of Medicine (US). Identifier NCT02978677. Proton dose escalation for patients with atypical or anaplastic meningiomas. https://www.clinicaltrials.gov/ct2/show/NCT02978677?cond=Meningioma&rank=8. Published 2016.
ClinicalTrials.gov. Bethesda [MD]: National Library of Medicine (US). Identifier NCT01166321. Carbon ion radiotherapy for atypical meningiomas (MARCIE). https://www.clinicaltrials.gov/ct2/show/NCT01166321?cond=Meningioma&rank=4. Published 2010.
ClinicalTrials.gov. Bethesda [MD]: National Library of Medicine (US). Identifier NCT03279692. Phase II trial of Pembrolizumab in recurrent or residual high grade meningioma.
ClinicalTrials.gov. Bethesda [MD]: National Library of Medicine (US). Identifier NCT02648997. A study of Nivolumab in adult participants with recurrent high-grade meningiomas. https://www.clinicaltrials.gov/ct2/show/NCT02648997?cond=Meningioma&rank=2. Published 2016.
Henzel M, Gross MW, Hamm K, et al. Stereotactic radiotherapy of meningiomas: Symptomatology, acute and late toxicity. Strahlentherapie und Onkol. 2006. doi:10.1007/s00066-006-1535-7.
Starke R, Kano H, Ding D, et al. Stereotactic radiosurgery of petroclival meningiomas: A multicenter study. J Neurooncol. 2014. doi:10.1007/s11060-014-1470-x.
Kreil W, Luggin J, Fuchs I, Weigl V, Eustacchio S, Papaefthymiou G. Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry. 2005. doi:10.1136/jnnp.2004.049213.
Kollová A, Liščák R, Novotný J, Vladyka V, Šimonová G, Janoušková L. Gamma Knife surgery for benign meningioma. J Neurosurg. 2007. doi:10.3171/JNS-07/08/0325.
Lee JYK, Niranjan A, McInerney J, Kondziolka D, Flickinger JC, Lunsford LD. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg. 2002. doi:10.3171/jns.2002.97.1.0065.
Skeie BS, Enger PO, Skeie GO, Thorsen F, Pedersen PH. Gamma knife surgery of meningiomas involving the cavernous sinus: Long-term follow-up of 100 patients. Neurosurgery. 2010. doi:10.1227/01.NEU.0000366112.04015.E2.
DOI: http://dx.doi.org/10.18103/imr.v4i3.697
Refbacks
- There are currently no refbacks.